By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado.

YEAR FOUNDED:

April 20, 2009

LEADERSHIP:

Founders: Patrick Mahaffy, and Erle Mast

CEO and Co-founder: Patrick Mahaffy

CMO (Medical): Lindsey Rolfe

JOBS:

Please click here for Clovis Oncology job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

All Products


Key Statistics


Email: info@clovisoncology.com
Ownership: Public

Web Site: Clovis Oncology
Employees:
Symbol: CLVS
 









Company News
Clovis Oncology (CLVS) Announces Q3 2016 Operating Results And Corporate Update 11/4/2016 10:57:21 AM
Clovis Oncology (CLVS) To Announce Third Quarter 2016 Financial Results And Host Webcast Conference Call On November 3 10/27/2016 11:50:09 AM
Lonza Group (LZAGY.PK) And Clovis Oncology (CLVS) Sign Strategic Long-Term Manufacturing Agreement To Secure Supply Of Rucaparib 10/27/2016 9:35:22 AM
Clovis Oncology (CLVS) Stock Hammered After Revealing Mixed Results for Rucaparib 10/7/2016 7:57:10 AM
Clovis Oncology (CLVS) Announces Rucaparib Data Presentations At ESMO 2016 Congress 9/28/2016 11:50:15 AM
Clovis Oncology (CLVS) (Once Again) Becomes a Takeover Topic, But Some Wonder Whether It's All Hype 9/23/2016 7:53:02 AM
What's PARP? Meet Two of Biotech's Newest M&A Targets: Tesaro (TSRO) and Clovis Oncology (CLVS) 9/15/2016 6:33:52 AM
Clovis Oncology (CLVS) Stock Jumps as FDA Skips Review Panel for New Cancer Drug 9/9/2016 5:50:31 AM
Clovis Oncology (CLVS) Rockets as FDA Agrees to Priority Review of Rucaparib NDA 8/24/2016 6:10:19 AM
Clovis Oncology (CLVS) Announces Q2 2016 Operating Results and Corporate Update 8/9/2016 10:52:19 AM
12345678910...
//-->